A potentially life-saving treatment containing venom from one of the world’s deadliest spiders is one step closer to human trials, thanks to a $23 million investment in a Brisbane start-up.
An IMB PhD student will use a prestigious foreign exchange scholarship to progress his work on developing medicines from nature. Isaac Tucker is harnessing molecules found in the venom of Australian spiders to develop treatments for neurological and gastrointestinal diseases.
IMB virologist Dr Larisa Labzin answers questions on long COVID and whether scientists could eventually develop a vaccine against all COVID-19 variants.
IMB researchers will tackle fundamental questions with $4.5 million of support from the NHMRC Idea Grants, including the researching devastating neural tube defects.
Australia may soon have the jump on cane toads after a not-for-profit was granted an exclusive licence to market an IMB-designed bait for the invasive pests.
Drug discovery research at IMB has been given a $12.9 million boost of Australian Government funding, to push the boundaries for more targeted, efficient new medicines.